Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of $13.05 million as of December 5, 2025. Its market cap has decreased by -91.43% in one year.

Market Cap

13.05M

Enterprise Value

35.67M

Revenue

65.09M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 13.05M, a decrease of -98.93%. That is a compound annual growth rate of -34.86%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	12.19M	-91.15%
Dec 31, 2024	137.84M	-23.47%
Dec 29, 2023	180.11M	-24.70%
Dec 30, 2022	239.19M	-59.17%
Dec 31, 2021	585.77M	-29.79%
Dec 31, 2020	834.26M	561.07%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	558.58M
Glass House Brands	531.36M
CytoDyn	403.93M
American Oncology Network	367.13M
Northwest Biotherapeutics	364.92M
Silence Therapeutics	336.78M
Nika Pharmaceuticals	259.91M

Market Cap Rankings